Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Curevac N.V. (CVAC)

Curevac N.V. (CVAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 734,326
  • Shares Outstanding, K 223,880
  • Annual Sales, $ 58,180 K
  • Annual Income, $ -281,580 K
  • 60-Month Beta 2.62
  • Price/Sales 12.58
  • Price/Cash Flow N/A
  • Price/Book 1.90
Trade CVAC with:

Options Overview Details

View History
  • Implied Volatility 113.18% ( -18.68%)
  • Historical Volatility 60.06%
  • IV Percentile 62%
  • IV Rank 15.97%
  • IV High 475.53% on 04/18/24
  • IV Low 44.29% on 03/21/24
  • Put/Call Vol Ratio 10.00
  • Today's Volume 11
  • Volume Avg (30-Day) 79
  • Put/Call OI Ratio 0.42
  • Today's Open Interest 4,728
  • Open Int (30-Day) 4,374

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 0.67
  • Number of Estimates 2
  • High Estimate 1.64
  • Low Estimate -0.31
  • Prior Year -0.24
  • Growth Rate Est. (year over year) +379.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.69 +22.08%
on 09/06/24
3.44 -4.36%
on 09/13/24
+0.05 (+1.54%)
since 08/16/24
3-Month
2.69 +22.08%
on 09/06/24
3.87 -14.99%
on 07/18/24
+0.04 (+1.23%)
since 06/18/24
52-Week
2.21 +48.53%
on 04/25/24
8.04 -59.08%
on 09/19/23
-4.47 (-57.60%)
since 09/18/23

Most Recent Stories

More News
Analysts Predict Strong Growth for Cancer Vaccine Market: Key Biotech Stocks to Consider

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – Back in 2022, Nature published...

BIOV.CN : 0.0650 (+8.33%)
BVAXF : 0.0442 (-1.78%)
BNTX : 115.62 (-7.29%)
CVAC : 3.29 (+0.30%)
VXRT : 0.9001 (-2.64%)
IBRX : 3.42 (+3.01%)
CureVac Advances Cancer Vaccine Candidate CVGBM to Part B of Phase 1 Study in Patients with Resected Glioblastoma

First patient administered in dose-confirmation Part B of Phase 1 study with mRNA-based, multiepitope cancer vaccine candidate CVGBM

CVAC : 3.29 (+0.30%)
GSK and CureVac to Restructure Collaboration into New Licensing Agreement

GSK acquires full rights to develop, manufacture and commercialize globally mRNA candidate vaccines for influenza and COVID-19, including combinations

CVAC : 3.29 (+0.30%)
Why CureVac Stock Plunged Today

A German court temporarily suspended proceedings in CureVac's IP lawsuit against BioNTech.

PFE : 29.75 (-0.27%)
CVAC : 3.29 (+0.30%)
BNTX : 115.62 (-7.29%)
3 Stocks to Buy For the COVID Resurgence

The cold and flu season is upon us, but COVID-19 cases and hospitalizations have also increased recently. The Centers for Disease Control (CDC) will be voting

MRNA : 69.86 (-2.96%)
NVAX : 12.56 (-2.86%)
PFE : 29.75 (-0.27%)
ALNY : 273.15 (-0.48%)
ABUS : 4.13 (+1.23%)
BNTX : 115.62 (-7.29%)
CVAC : 3.29 (+0.30%)
LGF-A : N/A (N/A)
Why Shares of CureVac Jumped This Week

The company, which focuses on mRNA therapies, began a phase 1 trial for its cancer vaccine candidate.

GSK : 42.43 (-0.31%)
CVAC : 3.29 (+0.30%)
Why CureVac Stock Leaped 12% Higher Today

The war on cancer advances with the German company's latest clinical development.

CVAC : 3.29 (+0.30%)
Pre-Market Brief: Stocks Mostly Lower As Recession Worries Outweigh Cooler Inflation Data

March S&P 500 futures (ESH23) are trending down -0.41% this morning after three major U.S. benchmark indices ended the regular session lower as weak economic data and hawkish comments from Federal Reserve...

ESH23 : 3,957.05s (-0.09%)
CVAC : 3.29 (+0.30%)
AA : 34.34 (+1.09%)
NTLA : 22.52 (-0.13%)
DFS : 136.11 (-1.07%)
ZYME : 12.52 (+1.79%)
VNO : 38.88 (+3.40%)
Why CureVac's Shares Jumped on Tuesday

The stock rose for the third consecutive day.

CVAC : 3.29 (+0.30%)
Unusual Options Activity Booms for Novavax (NVAX) But Concerns Remain

Unsurprisingly, positive sentiment toward Novavax’s change of leadership bolstered unusual options activity for NVAX stock. Still, prospective investors need to tread very carefully.

NVAX : 12.56 (-2.86%)
HRMY : 38.34 (-1.21%)
TEVA : 17.88 (+0.17%)
PFE : 29.75 (-0.27%)
CVAC : 3.29 (+0.30%)

Business Summary

CureVac B.V. is a clinical-stage biopharmaceutical company. It engages in developing medicines based on messenger ribonucleic acid. The company's lead clinical programs include CV8102. CureVac B.V. is based in Germany.

See More

Key Turning Points

3rd Resistance Point 3.51
2nd Resistance Point 3.44
1st Resistance Point 3.36
Last Price 3.29
1st Support Level 3.21
2nd Support Level 3.14
3rd Support Level 3.06

See More

52-Week High 8.04
Fibonacci 61.8% 5.81
Fibonacci 50% 5.13
Fibonacci 38.2% 4.44
Last Price 3.29
52-Week Low 2.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar